Cargando…
Model Informed Drug Development and Regulation in China: Challenges and Opportunities
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389345/ https://www.ncbi.nlm.nih.gov/pubmed/30407746 http://dx.doi.org/10.1002/psp4.12368 |
| _version_ | 1783397935519629312 |
|---|---|
| author | Li, Li Han, Hongcan Wang, Jun Wei, Chunmin Wang, Yuzhu Li, Min Zhou, Yu Yang, Jinbo |
| author_facet | Li, Li Han, Hongcan Wang, Jun Wei, Chunmin Wang, Yuzhu Li, Min Zhou, Yu Yang, Jinbo |
| author_sort | Li, Li |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6389345 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63893452019-03-07 Model Informed Drug Development and Regulation in China: Challenges and Opportunities Li, Li Han, Hongcan Wang, Jun Wei, Chunmin Wang, Yuzhu Li, Min Zhou, Yu Yang, Jinbo CPT Pharmacometrics Syst Pharmacol Perspectives John Wiley and Sons Inc. 2019-01-04 2019-02 /pmc/articles/PMC6389345/ /pubmed/30407746 http://dx.doi.org/10.1002/psp4.12368 Text en © 2018 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Perspectives Li, Li Han, Hongcan Wang, Jun Wei, Chunmin Wang, Yuzhu Li, Min Zhou, Yu Yang, Jinbo Model Informed Drug Development and Regulation in China: Challenges and Opportunities |
| title | Model Informed Drug Development and Regulation in China: Challenges and Opportunities |
| title_full | Model Informed Drug Development and Regulation in China: Challenges and Opportunities |
| title_fullStr | Model Informed Drug Development and Regulation in China: Challenges and Opportunities |
| title_full_unstemmed | Model Informed Drug Development and Regulation in China: Challenges and Opportunities |
| title_short | Model Informed Drug Development and Regulation in China: Challenges and Opportunities |
| title_sort | model informed drug development and regulation in china: challenges and opportunities |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389345/ https://www.ncbi.nlm.nih.gov/pubmed/30407746 http://dx.doi.org/10.1002/psp4.12368 |
| work_keys_str_mv | AT lili modelinformeddrugdevelopmentandregulationinchinachallengesandopportunities AT hanhongcan modelinformeddrugdevelopmentandregulationinchinachallengesandopportunities AT wangjun modelinformeddrugdevelopmentandregulationinchinachallengesandopportunities AT weichunmin modelinformeddrugdevelopmentandregulationinchinachallengesandopportunities AT wangyuzhu modelinformeddrugdevelopmentandregulationinchinachallengesandopportunities AT limin modelinformeddrugdevelopmentandregulationinchinachallengesandopportunities AT zhouyu modelinformeddrugdevelopmentandregulationinchinachallengesandopportunities AT yangjinbo modelinformeddrugdevelopmentandregulationinchinachallengesandopportunities |